Inpharma Weekly

, Volume 1529, Issue 1, pp 8–8 | Cite as

Gemcitabine increases efficacy of standard chemo for NSCLC

Clinical study
  • 5 Downloads

Keywords

Lung Cancer Survival Time Median Survival Gemcitabine Partial Response 

Copyright information

© Adis International Ltd 2006

Personalised recommendations